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Homeward Bound: How Do Skin 
Dendritic Cells Find Their Way into 
the Lymph System?
Sam T. Hwang1
The success of the adaptive immune system relies upon the transport of 
antigens by dendritic cells (DCs) from skin via lymphatic vessels to lymph nodes 
where DCs present antigen to T cells.  Little is known about the requirements for 
so-called “reverse transmigration” (RT).  Torzicky et al. in this issue demonstrate 
that CD31, CD99, and CXCR4 play key roles in RT, suggesting that adhesion 
occurs in a defined sequence during the passage of DC into lymphatics.  
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The success of the adaptive immune 
system relies in part on the efficient 
transport of antigens by specialized 
antigen-presenting cells (e.g., dendrit-
ic cells (DCs) from barrier tissue such 
as skin (where infectious organisms 
first invade) to secondary lymphoid 
organs such as lymph nodes (LNs), 
where the DCs present antigen to naive 
and memory T cells (Randolph et al., 
2005). Although this process is critical 
for immune cell priming, much less is 
known about it, including the cyto-
kines and adhesion molecules that are 
required, than about the effector phase 
of adaptive immunity in which T cells 
(and other leukocytes) migrate from 
the blood stream to tissue by first tran-
siently stopping (rolling), firmly arrest-
ing, and finally crawling (diapedesis) 
between blood vascular endothelial 
cells (BVECs) to emerge on the tissue 
side of the blood vessel (Mackay, 1999).
Lymphatic vessels have long been 
appreciated in humans. Veiled cells 
resembling macrophages were iden-
tified more than 40 years ago in 
lymphatic fluid (Smith et al., 1970). 
These veiled cells were eventually rec-
ognized to be potent antigen-presenting 
cells called DCs; in skin, they are 
composed primarily of epidermal 
DCs called Langerhans cells (LCs) and 
dermal DCs.
The complex route of epidermal LCs 
has been of particular interest because 
these cells must leave the epidermis 
prior to entering lymphatic vessels. 
Migration of LCs appears to be associ-
ated with the activation of resting LCs 
by inflammatory triggers such as IL-1b 
and tumor necrosis factor-a. The latter 
two cytokines not only cause LCs to 
strongly upregulate major histocom-
patibility complex class II and costim-
ulatory molecules but also may induce 
the generation of lymphangiogenic 
cytokines such as vascular endothelial 
growth factor-C, which increase the 
number of lymphatic vessels at sites 
of inflammation. As LCs mature, 
they also downregulate expression 
of E-cadherin (Schwarzenberger and 
Udey, 1996), which may anchor 
LCs to keratinocytes in the epider-
mis and initiate expression of matrix 
metalloproteinases, allowing them to 
pass through the basement membrane 
(Angeli and Randolph, 2006).
Two key membrane receptors that 
are upregulated with LC/DC matura-
tion are the chemotactic receptors CC 
chemokine receptor-7 (CCR7) and 
CXC chemokine receptor-4 (CXCR4). 
The role of CCR7 and its two ligands 
(CCL19 and -21) in lymphatic traffick-
ing is better understood because CCR7-
deficient knockout mice (CCR7-KO) 
(Foerster et al., 1999) and paucity of LN 
T cells (plt) mice (Gunn et al., 1999), 
which lack expression of select CCR7 
chemokine ligands (CCL19/21) at the 
periphery and within LNs, both exhibit 
small peripheral LNs. This phenotype 
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is caused by the inability of T cells to 
effectively migrate to LNs from periph-
eral tissue sites via lymphatics and from 
the blood. Furthermore, in both types 
of mice, DCs from the periphery show a 
marked defect in their ability to migrate 
to peripheral LNs. Similarly to T cells, 
DCs require CCR7 in order to traverse 
from the periphery to regional LNs. This 
is shown in elegant adoptive transfer 
experiments demonstrating that DCs 
from CCR7 KO mice fail to migrate to 
peripheral LNs after implantation in the 
subcutis (Martin-Fontecha et al., 2003), 
in fluorescein isothiocyanate (FITC)-
skin painting experiments (Foerster et 
al., 1999), and in experiments in which 
a neutral izing antibody against the 
CCR7 ligand, CCL21, blocks migration 
of radio labeled DCs to peripheral LNs 
(Saeki et al., 1999). CCR7 also appears 
to play a role in the mechanism by 
which cancer cells metastasize to the 
LNs (Fang and Hwang, 2009; Wiley et 
al., 2001).
Central to the successful migration 
of DCs to the LNs is the interaction 
between DCs and lymphatic endotheli-
um, which remains an area of consider-
able controversy. It is unclear whether 
DCs passively enter lymphatic vessels 
through spaces between adjacent lym-
phatic endothelial cells (LECs)—which 
are large enough to allow particles to 
pass—or whether they must squeeze 
themselves through closed junctions 
between LECs (Stoitzner et al., 2002). 
Because of the small size of murine 
lymphatic vessels, it has been difficult 
to assess these interactions in vivo in 
mice. Most of our information comes 
from painting FITC on the surface of 
skin, which not only is taken up by 
LCs and other skin antigen-presenting 
cells but also triggers an inflammatory 
response that induces DC maturation. 
Labeled DCs can then be detected 
hours or days later in the draining LNs, 
allowing investigators to indirectly 
infer the action of a particular protein 
based on specific interventions. Using 
this technique, peptide antagonists 
of CXCR4 were shown to reduce the 
migration of FITC-labeled LCs from the 
skin to draining LNs, suggesting a role 
for CXCR4, without specifying where it 
is required in this complicated pathway 
(Kabashima et al., 2007a).
In this issue, Torzicky et al. exam-
ine the role of adhesion molecules 
in the RT of monocyte-derived DCs 
through LEC monolayers. The inves-
tigators first noted that CD31 and 
CD99 were expressed by LECs and 
human LECs from skin explants. In 
contrast to BVECs, on which CD31 and 
CD99 both localize to cell junctions 
(Mamdouh, 2009), Torzicky and col-
leagues observed that CD31 in human 
skin was enhanced on LEC cell junc-
tions whereas CD99 and podoplanin 
were found on the luminal side of the 
lymphatic vessel from skin. CD31 (also 
known as PECAM-1) is an adhesion 
molecule that forms homo-oligomers 
between cells, possibly triggering 
an increase in the strength of adhe-
sion of integrins. It is highly expressed 
on many leukocytes and BVECs, but 
somewhat more weakly on LECs. 
CD99 is a heavily glycosylated trans-
membrane protein that is expressed 
by most hematopoietic cells as well as 
endothelial cells. Blocking antibodies 
to CD99 appears to “freeze” mono-
cytes midway in the junction between 
BVECs in transmigration assays, where-
as CD31 blocking antibodies seem to 
prevent monocytes from even entering 
the junction (Schenkel et al., 2002). 
Thus, for migration from the luminal 
side of the blood vessel, the role of 
CD31 seems to be spatially proximal 
to the role of CD99.
Although CD31 and CD99 have 
been shown to play roles in leukocyte 
diapedesis in BVECs, their roles in DC/
LEC trafficking are unknown. To pro-
vide a reductionist model system by 
which to study the adhesion molecules 
required for RT, Torzicky et al. (2012) 
cultured telomerase-expressing human 
LECs on Transwell filter membranes 
such that the basolateral surface of 
the monolayer was on the bottom, but 
then flipped the Transwell filters over, 
added cultured mDCs to the top cham-
ber, and placed chemoattractants such 
as CXCL12 in the bottom chamber to 
generate a chemokine gradient.
Figure 1. model of Lc migration from skin to regional lymph nodes. Skin dendritic cells (DCs) 
such as Langerhans cells (LCs) are activated by pathogens and/or skin inflammatory cytokines. After 
downregulating E-cadherin and upregulating CCR7, CXCR4, and metalloproteinases, LCs enter the 
dermis. It is still not clear whether a gradient of CCR7 ligands (CCL21 or CCL19) or CXCR4 ligands 
(CXCL12) attracts LCs toward lymphatic vessels. Both ligands can be produced by lymphatic endothelial 
cells (LECs). Homo-oligomeric interaction between first CD31 at the intercellular junction between 
LECs and then CD99 on the luminal surface of lymphatic vessels may be requisite adherence events 
that eventually lead to LCs’ passage into the lumen of the lymphatic vessel, where lymphatic flow may 
propel these cells to the regional draining lymph node. Both CD31 and CD99 are expressed by DCs and 
LECs. MMPs, matrix metalloproteinases; TNF, tumor necrosis factor.
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In this modified Transwell assay, 
CXCL12 had a powerful effect in 
attracting monocyte-derived DCs 
through the LEC monolayer barrier. 
CXCL12 and CCL21 were similar in 
their abilities to induce migration. 
Treatment of either the LECs or the 
monocyte-derived DCs with anti-CD31 
or -99 monoclonal antibodies (mAbs) 
resulted in a substantial inhibition of RT 
migration, suggesting that these mol-
ecules play a key role in this interac-
tion. Treating either cell with antibody 
had an inhibitory effect, substantiating 
the role of homo-oligomerization of 
these molecules in their mechanism of 
adhesion. Blocking with a combina-
tion of both mAbs did not yield better 
inhibition, and one might infer that 
these antibodies target discrete steps in 
transmigration. Based on the distribu-
tion of CD99 (on the luminal surface) 
and CD31 (between LEC junctions) 
observed by these investigators, one 
might hypothesize that the action of 
CD31 is proximal to that of CD99 dur-
ing the RT migration of DCs, analogous 
to their proposed roles in BVEC traffick-
ing (see above).
Torzicky et al. (2012) also demon-
strated that in vitro LECs are capable 
of producing CXCL12, which can 
be modestly enhanced by treating 
LECs with inflammatory cytokines. 
When staining human skin samples, 
they noted that CXCL12 was located 
in BVECs and LECs but could not be 
detected in fibroblasts, suggesting that 
the LECs themselves may be important 
sources of CXCL12 for transmigration.
Because the monolayer LEC RT model 
cannot simulate the complex environ-
ment of skin, Torzicky et al. examined 
whether CXCL12, CD99, and CD31 
have a role in DC emigration, using a 
skin explant model. They quantitated 
the percentage of human leukocyte anti-
gen–DR+ cells found in the dermis (as a 
percentage of the total DCs in both epi-
dermis and dermis) as a measure of DC 
migration into the dermis. When they 
added CXCL12 to the culture medium, 
they observed a substantially higher frac-
tion of DCs in the dermis, and this was 
partially inhibited by mAbs to CD31 
and CD99. The effect of the anti-CD31 
and -CD99 mAbs is somewhat puzzling 
because they would not be expected 
to block DC migration into the dermis. 
Although measuring the ability of DCs to 
enter lymphatics would have been very 
helpful, this is technically challenging in 
frozen sections, and a quantitative mea-
sure was not shown by the authors. In 
any event, the inhibitory effect was mod-
est and may have occurred for other rea-
sons. It is clear, however, that CXCL12 is 
a powerful stimulant for DCs to migrate 
from the epidermis to the dermis. Others 
have shown that CXCL12 can drive DC 
migration from skin explants into culture 
medium but that CCL21 has a more pro-
found effect (Saeki et al., 1999). As noted 
by others (Randolph et al., 2005), skin 
explant models have limitations, includ-
ing poor viability of the cultured tissue. 
Given that Kabashima et al. (2007b) 
have reported that CXCR4 activation can 
increase DC survival, it is also possible 
that the addition of CXCL12 to the cul-
ture medium increased DC viability.
In summary, Torzicky et al. (2012) 
have shown that CD31, CD99, and 
CXCR4 play notable roles in RT in vitro 
and ex vivo. Their localization studies 
of CD31 and CD99 provide valuable 
insight into the possibility that adhesion 
occurs in a defined sequence during the 
passage of DCs through LECs. Although 
not entirely conclusive, their ex vivo 
studies help to answer the question of 
whether DC entry into lymphatics is a 
passive or active process, suggesting that 
there are active mechanisms at hand. In 
vivo studies would be needed to yield 
definitive results. Based on their new 
data, however, one can propose a model 
of DC interaction with LECs that involves 
these molecules and, possibly, CCR7 
ligands as well (Figure 1). Although pure-
ly speculative at this point, one wonders 
whether CD99 and CD31 on the sur-
face of LCs (DCs) can be redistributed 
to adhere to these molecules on LECs 
in such a way that they act as anchoring 
points for further migration.
Finally, although they demonstrate 
a role for CXCR4, Torzicky et al. have 
not directly addressed the relative 
importance of CCR7 compared with 
CXCR4 in DC migration. The use of 
neutralizing anti-CCL21/CCL19 anti-
bodies in this skin explant model 
would have helped to address this 
important, yet unanswered, question. 
Moreover, more precise localization 
of the chemokines involved might also 
explain their roles in DC migration. 
There is still much to be answered, 
but these studies provide a new 
perspective on how DCs make their 
fascinating journey from skin to LN.
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Demonstration of Melanosome 
Transfer by a Shedding  
Microvesicle Mechanism
Glynis Scott1
The process of melanosome transfer has fascinated pigment cell biologists 
for decades. Whole-organelle transfer is a unique property of melanocytes, 
suggesting that the biologic underpinnings of the process reflect melanocyte- 
and keratinocyte-specific proteins and pathways. Although several mechanisms 
of melanosome transfer are likely to occur in the skin, Ando et al. focused on a 
new mechanism of melanosome transfer that involves release of melanosome-
containing globules, similar to shedding vesicles into the extracellular space, 
followed by uptake by keratinocytes. This model adds further complexity to the 
process of melanosome transfer in the skin.
Journal of Investigative Dermatology (2012) 132, 1073–1074. doi:10.1038/jid.2012.20
melanosome transfer: multiple models
Because melanocytes constitute a 
minority population in the epider-
mis, efficient transfer of melano-
somes (the organelle responsible for 
melanin synthesis) to keratinocytes is 
critical in providing photoprotection 
to the skin. The melanocyte has mul-
tiple dendrites, which contact basal 
as well as suprabasal keratinocytes. 
The biologic importance of melano-
some transfer is easily appreciated 
after exposure of skin, or melanocyte–
keratinocyte cocultures, to UVR, 
which induces increased synthesis of 
melanin, enhanced dendrite forma-
tion by melanocytes, and melanosome 
transfer. Disordered melanosome 
transfer due to defects in rab27a and 
myosin Va are seen in Griscelli syn-
drome, a rare autosomal recessive dis-
order characterized by partial albinism 
and immune deficiency (Barral et al., 
2002; Hume et al., 2002; Novak et al., 
2002). Understanding the nature of 
this process has clinical implications 
for photocarcinogenesis and disorders 
of pigmentation, including melasma 
and postinflammatory pigmentary dis-
orders.
Historical models of melanosome 
transfer were based primarily on static 
electron micrographs of cocultures 
and low-resolution video microscopy. 
Despite these technical limitations, 
investigators were able to propose sev-
eral mechanisms, including phagocy-
tosis of dendrite tips by keratinocytes, 
individual melanosome “exocytosis,” 
and an “inoculation” model in which 
dendrite tips were inserted directly into 
the keratinocyte membrane (Okazaki 
et al., 1976; Yamamoto and Bhawan, 
1994). In 2002, using high-resolution 
time-lapse microscopy and electron 
micrographs, we identified a novel 
mechanism of melanosome trans-
fer through thin actin-based struc-
tures called “filopodia” and showed 
that the small GTP-binding protein 
Cdc42 stimulates melanosome trans-
fer (Scott et al., 2002). Transport of 
melanosomes along microtubules has 
been shown to be driven by the motor 
protein kinesin (Hara et al., 2000), and 
a critical receptor for melanosome 
uptake, PAR-2, has been identified on 
keratinocytes. The PAR-2 receptor is 
upregulated by UV irradiation, and it 
mediates the engulfment of melano-
somes in a mechanism similar to that 
of traditional phagocytosis-mediated 
processes (Seiberg, 2001; Sharlow et 
al., 2000).
Shedding microvesicles in  
melanosome transfer
In their study reported in this issue, 
Ando et al. used scanning electron 
microscopy and immunofluorescence 
microscopy of melanocytes in which 
the plasma membrane was stained to 
demonstrate the presence of “pigment 
globules” adhering to dendrites. 
Scanning electron microscopy showed 
that multiple filopodia were assoc iated 
with the pigment globules. The pig-
ment globules consisted of multiple 
melanosomes tightly packaged into a 
single membrane structure 2–7 μm in 
diameter. These structures resembled 
shedding microvesicles, which are 
single-membrane vesicles that are a 
vehicle for transport of a variety of 
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